Status:
SUSPENDED
Physical Activity Coaching in Patients with Post-COVID-19
Lead Sponsor:
University of Alcala
Collaborating Sponsors:
Colegio Profesional de Fisioterapeutas de la Comunidad de Madrid
Conditions:
Post-COVID-19 Syndrome
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This randomized clinical trial aims to compare the effects of a 12-week behavioral physical activity intervention (i.e., physical activity coaching) with usual care (i.e., World Health Organization re...
Detailed Description
Patients will be invited to participate via phone calls, and those interested will be scheduled to obtain their written informed consent and undergo a baseline assessment. Afterwards, they will be ra...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- At least, 18 years of age.
- Having been diagnosed of COVID-19, confirmed by a polymerase chain reaction \[PCR\] test or an antigen test, at one of the severity levels during the acute phase of the illness.
- Presenting a diagnosis of post-COVID-19, persistent COVID, or long COVID, involving the persistence of symptoms for at least three months after the acute phase of the illness (i.e., to reduce variability in the diagnosis, it is proposed that symptom persistence be for at least 12 months).
- Being included in a post-COVID-19 follow-up consultation (or another consultation - pulmonology, internal medicine - in the event of closure of a specific consultation) in the region of Madrid, Spain.
- Stable condition of symptoms and comorbidities (i.e., no major change in clinical status).
- Exclusion criteria:
- Presenting significant signs of cognitive decline, cardiovascular, neurological, and/or musculoskeletal disease that could hinder the performance of assessment tests and thus limit participation or pose a risk to their health.
- Particularly presenting the following conditions: cognitive disorders such as sequelae of Alzheimer's disease, senile dementia; comprehension disorders such as Wernicke's aphasia; cognitive-motor disorders such as hemiparesis/hemiplegia due to stroke; musculoskeletal disorders such as non-healed fractures, external prostheses (including prosthetic limbs for amputees); cardiovascular disorders such as unstable angina, recent acute myocardial infarction, among others.
- Medical history that interferes with the study's objectives or compromises its conclusions.
- Any health issues that limit life expectancy to less than one year.
- Medical, social, or geographical factor that may endanger the patient.
- Psycho-physical inability to complete assessment tests and questionnaires.
Exclusion
Key Trial Info
Start Date :
April 17 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2027
Estimated Enrollment :
162 Patients enrolled
Trial Details
Trial ID
NCT06165978
Start Date
April 17 2024
End Date
December 31 2027
Last Update
February 21 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Alcalá
Alcalá de Henares, Madrid, Spain, 28805